The Cell and Gene Therapy Catapult (CGT Catapult), a government-funded body encouraging the development of the advanced therapy sector, has published a report i 18 January 2024
The Medicines Control Authority of Zimbabwe (MCAZ) has signed a Memorandum of Understanding (MoU) with the South African Health Products Regulatory Authority (S 18 January 2024
US biopharma Emergent BioSolutions has secured a procurement contract with a maximum value up to $235.8 million to supply BioThrax (Anthrax Vaccine Adsorbed) fo 12 January 2024
Lif, the industry organization for Danish and foreign pharmaceutical companies in Denmark, has held a debate to discuss access to new medicines. 18 December 2023
US pharma trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has presented research suggesting the Inflation Reduction Act (IRA) could 18 December 2023
Specialty biopharma firm Emergent BioSolutions has been awarded a $75 million option under an existing agreement with the Biomedical Advanced Research and Devel 5 December 2023
Industry has renewed its criticism of the UK government after the publication of new terms for the statutory scheme for branded medicines. 5 December 2023
The UK Biobank has unveiled research based on its collection of genetic data, a record which now includes the participation of over half a million people. 1 December 2023
Several Latin American countries, given their processes of political change, are immersed in deep discussions about transforming their health systems, writes Th 29 November 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.